Immuron Limited (IMRN)
NASDAQ: IMRN
· Real-Time Price · USD
1.71
-0.03 (-1.72%)
At close: Jul 01, 2025, 1:01 PM
-1.72% (1D)
| Bid | 1.66 |
| Market Cap | 9.79M |
| Revenue (ttm) | 7.82M |
| Net Income (ttm) | -9.78M |
| EPS (ttm) | -0.83 |
| PE Ratio (ttm) | -2.06 |
| Forward PE | -92.5 |
| Analyst | Buy |
| Ask | 1.74 |
| Volume | 58,990 |
| Avg. Volume (20D) | 30,434 |
| Open | 1.78 |
| Previous Close | 1.74 |
| Day's Range | 1.56 - 1.78 |
| 52-Week Range | 1.50 - 2.87 |
| Beta | 0.51 |
About IMRN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol IMRN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for IMRN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts5 months ago
+8.59%
Immuron shares are trading higher after the compan...
Unlock content with
Pro Subscription
5 months ago
+1.52%
Immuron shares are trading higher after the company announced that it has submitted its Phase 2 study report to the FDA and is preparing for the the next steps toward its Phase 3 trial.
2 years ago · proactiveinvestors.co.uk
Immuron CEO highlights strong sales growth in business update presentationImmuron Ltd (NASDAQ:IMRN, ASX:IMC) CEO Steven Lydeamore highlighted the strong growth in sales of oral immunotherapeutic products in the company's February 2023 business update presentation for invest...
3 years ago · investorplace.com
IMRN Stock Alert: What Is the Huge Catalyst Sending Immuron Soaring?Today marks one of the best days for IMRN stock in a long time, with shares surging nearly 50% on the back of some impressive news. The post IMRN Stock Alert: What Is the Huge Catalyst Sending Immuron...
